Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2022-09-30 Annual Report
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2022
Annual Report Classification · 95% confidence The document is titled 'ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 30 JUNE 2022' and contains detailed audited consolidated financial statements including profit or loss, comprehensive income, financial position, and notes to the consolidated financial statements. It includes extensive financial data and analysis for the full fiscal year ended 30 June 2022. The document is about 15,000 characters long, which is substantial and contains the full report rather than just an announcement or a link to a report. The content matches the characteristics of an Annual Report or Annual Results filing, specifically an official yearly report covering company activity and full financial performance. Therefore, the appropriate classification is Annual Report (10-K). FY 2022
2022-09-30 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the date of a forthcoming board meeting to consider and approve the annual results for the year ended 30 June 2022 and the payment of a final dividend. It does not contain the actual annual report or financial results but merely informs about the meeting date and agenda. The document length is short (2392 characters), and it serves as a notice rather than a report. According to the 'MENU VS MEAL' rule, this is an announcement about a report, not the report itself. Therefore, it should be classified as a Regulatory Filing (RNS), which is the fallback category for such announcements that do not fit other specific categories.
2022-09-20 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically focusing on authorized and issued share capital, share options, convertible bonds, and other share-related movements for Sinopharm Tech Holdings Limited. It includes detailed tables of share capital changes, share options, convertible bonds, and confirmations related to securities issuance. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. It is a regulatory submission reporting on share capital and securities movements for the month ended 31 August 2022. This type of document is a regulatory filing related to share capital and securities movements but does not constitute a full financial report, earnings release, or management discussion. It is not an announcement of voting results, nor a proxy statement, nor a remuneration report. It is a formal regulatory filing required by the stock exchange to disclose share capital movements and related confirmations. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-09-06 English
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles, including executive, non-executive, and independent non-executive directors, as well as the composition of board committees. There is no financial data, no mention of a report or meeting, and no indication of changes in management or voting results. This is a straightforward announcement of board composition and committee membership, which fits the category of Board/Management Information (MANG). The document length is short and focused solely on board information, confirming this classification.
2022-09-05 English
CHANGE OF DIRECTORS AND APPOINTMENT OF HONORARY CONSULTANT
Board/Management Information Classification · 100% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding changes in the company's board of directors and the appointment of an honorary consultant. It details the resignation of two executive directors, the appointment of two new executive directors, and the appointment of an honorary consultant, including their backgrounds and terms. There is no financial data, no discussion of financial results, no mention of annual or interim reports, no voting results, no legal proceedings, and no other types of filings. The content clearly fits the category of announcements about changes in the company's board or senior management. Therefore, the document is best classified as Board/Management Information (MANG). The document length and detail support this classification with high confidence.
2022-09-05 English
CHANGE OF HEAD OFFICE AND PRINCIPAL PLACE OF BUSINESS IN HONG KONG
Board/Management Information Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a change of the company's head office and principal place of business in Hong Kong. It is a formal notification made by the Board of Directors. There is no financial data, no discussion of financial results, no mention of annual or interim reports, no voting results, no legal proceedings, no capital changes, and no other detailed report content. The document is short (2332 characters) and serves as a regulatory announcement about a corporate administrative change. This fits the category of Board/Management Information (MANG), which includes announcements of changes related to the company's board or management or other corporate administrative changes. Therefore, the correct classification is MANG with high confidence.
2022-09-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.